IDStewardship

APRIL 14, 2024

In this article a comparison of Rebyota versus Vowst is provided, to help learners differentiate these two fecal microbiota therapies. Article Posted 14 April 2024 What is Clostridioides difficile ? Rebyota, a solution delivered via enema, was the first FMT product to be FDA-approved. Authored by: Natalie Boyer, Pharm.D.

FDA 324

FDA Hospitals Communication 324

The Checkup by Singlecare

FEBRUARY 1, 2024

Food and Drug Administration (FDA) to treat opioid use disorder and alcohol use disorder. When to talk to a healthcare provider about naltrexone interactions While many naltrexone interactions are discussed in this article, there may be other interactions we haven’t discussed.

Communication 92

Communication Dosage FDA 92

DiversifyRx

NOVEMBER 24, 2023

While DSCSA (the Drug Supply Chain Security Act) enforcement is postponed until November 2024, it is critical to move forward in becoming compliant sooner rather than later. If you think that doesn’t happen nowadays, here’s an article about recent counterfeit HIV medications. To achieve this, the U.S.

Independent Pharmacies 52

Independent Pharmacies Packaging Documentation FDA 52

ISPE

SEPTEMBER 8, 2023

This article describes the goal of the initiative, characterizes the anticipated challenges to innovation, summarizes the industry’s need to innovate, and discusses regulatory initiatives that are currently in progress, including learnings from the recent pandemic. www.fda.gov/about-fda/oncology-center-excellence/project-orbis.

FDA 52

FDA Dosage Documentation Communication 52